Effect of colestipol and clofibrate on plasma lipid and lipoproteins in Type IIa hyperlipoproteinemia
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 30 (6) , 605-609
- https://doi.org/10.1016/0026-0495(81)90140-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Long-term trial with colestipol plus clofibrate in familial hypercholesterolemiaAtherosclerosis, 1978
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: A cooperative lipoprotein phenotyping studyJournal of Chronic Diseases, 1977
- One‐year trials with halofenate, clofibrate, and placeboClinical Pharmacology & Therapeutics, 1976
- Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese MenNew England Journal of Medicine, 1976
- Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemiaJAMA, 1972
- Metabolic relationships among the plasma lipoproteinsJournal of Clinical Investigation, 1972
- Treatment of hyperlipidemiasThe American Journal of Medicine, 1968
- Ischemic Heart Disease, Atherosclerosis, and LongevityCirculation, 1966